Ayala Pharmaceuticals Financials

Ayala Pharmaceuticals Stock Summary

Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes technology antigen delivery products in the United States. Advaxis, Inc. was founded in 2002 and is based in Monmouth Junction, New Jersey. Advaxis operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 14 people.

Ayala Pharmaceuticals Key Financial Ratios

There are many critical financial ratios that Ayala Pharmaceuticals' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Ayala Pharmaceuticals reports annually and quarterly.

Ayala Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Ayala Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Ayala Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ayala Pharmaceuticals competition to find correlations between indicators driving Ayala Pharmaceuticals's intrinsic value. More Info.Ayala Pharmaceuticals is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ayala Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Ayala Pharmaceuticals Market Pulse

Along with financial statement analysis, the daily predictive indicators of Ayala Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Ayala Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ayala Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Ayala OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ayala Pharmaceuticals's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

If you are still planning to invest in Ayala Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ayala Pharmaceuticals' history and understand the potential risks before investing.